92054 ⎘
Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups polycyclic
Sub-classes:RESIST COMPOSITION, RESIST PATTERN FORMING METHOD, COMPOUND AND ACID DIFFUSION CONTROL AGENT
#2METABOTROPIC GLUTAMATE RECEPTOR POSITIVE ALLOSTERIC MODULATORS (PAMS) AND USES THEREOF
#3SHP2-Targeting Small Molecules For Use As Anti-Cancer Agents
#4NOVEL AROMATIC COMPOUNDS
#5RADIATION-SENSITIVE RESIN COMPOSITION, METHOD OF FORMING RESIST PATTERN, AND COMPOUND
#6METHOD FOR PRODUCING BENZOPYRANONE COMPOUND AND NOVEL INTERMEDIATE USED THEREIN
#7NOVEL AROMATIC COMPOUNDS
#8NOVEL AROMATIC COMPOUNDS
#9Compound for modulating DDAH and ADMA levels, as well as methods of using thereof to treat disease
#10ESTERS AND CARBAMATES AS MODULATORS OF SODIUM CHANNELS
#11NOVEL AROMATIC COMPOUNDS
#12Compound for modulating DDAH and ADMA levels, as well as methods of using thereof to treat disease
#13Aromatic compounds
#14Synthetic processes and intermediates
#15Benzoic acid compounds for reducing uric acid
#16Catalytic glycosylation with designer thioglycoside and novel protecting groups for same and for synthesis of oligosaccharides
#17SKIN WHITENING AGENT CONTAINING NOVEL CYCLIC COMPOUND
#18Aniline derivatives, their preparation and their therapeutic application
#19Homochiral metal-organic framework with enantiopure pillar[5]arene active domains
#20Liquid crystal compound, liquid crystal composition and liquid crystal display device
#21Substituted bicyclic aromatic compounds as S-nitrosoglutathione reductase inhibitors
#22Aniline derivatives, their preparation and their therapeutic application
#23Anti-virulence compositions and methods
#24Substituted bicyclic aromatic compounds as S-nitrosoglutathione reductase inhibitors
#25ATGListatin and pharmaceutical composition comprising the same
#26Catalytic glycosylation with designer thioglycoside and novel protecting groups for same and for synthesis of oligosaccharides
#27BENZOIC ACID COMPOUNDS FOR REDUCING URIC ACID
#28Functionalized phenolic compounds and polymers therefrom
#29Substituted bicyclic aromatic compounds as S-nitrosoglutathione reductase inhibitors
#30Substituted bicyclic aromatic compounds as S-nitrosoglutathione reductase inhibitors
#31Fluorinated graphene oxide and preparation method thereof
#32LIPASE INHIBITORS
#33Acylpiperazinones and their use as pharmaceuticals
#342,4,5-TRIAMINOPHENOLS AND RELATED COMPOUNDS
#35METHOD FOR PREPARING CHEMICAL COMPOUNDS OF INTEREST BY NUCLEOPHILIC AROMATIC SUBSTITUTION OF AROMATIC CARBOXYLIC ACID DERIVATIVES SUPPORTING AT LEAST ONE ELECTRO-ATTRACTIVE GROUP
#36Process and intermediates for preparing integrase inhibitors
#37Acylpiperazinones and their use as pharmaceuticals
#38Anhydride derivatives of 2-(S)-(6-methoxy-2-naphtyl)-propanoic acid, preparation method and use thereof
#39GLYCINE B ANTAGONISTS
#40SALICYLIC ACID DERIVATIVES BEING FARNESYL PYROPHOSPHATE SYNTHASE ACTIVITY INHIBITORS
#41Anti-virulence compositions and methods
#42Novel Compounds
#43Process and intermediates for preparing integrase inhibitors
#44Compounds, compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding
#45Process for the synthesis of fluorinated ethers of aromatic acids
#46Gossypol and apogossypol derivatives, preparation thereof and uses thereof
#47Therapeutic Molecules and Methods-1
#48SUBSTITUTED 2-NAPHTHOIC ACIDS AS ANTAGONISTS OF GPR105 ACTIVITY
#49Thyroid receptor ligands
#50Process and intermediates for preparing integrase inhibitors
#51Diphenyl ether compound, process for producing the same, and use
#52CYCLIC COMPOUND, PHOTORESIST BASE, PHOTORESIST COMPOSITION, MICROFABRICATION PROCESS, AND SEMICONDUCTOR DEVICE
#53Unsymmetrical aromatic ether diacids and absorbable polymers therefrom
#54Process for the synthesis of ethers of aromatic acids
#55Method for the treatment of metabolic disorders
#56Bis(formylphenyl)alkane and novel polynuclear phenol derived from the same
#57Process for the synthesis of ethers of aromatic acids
#58Vitamin D receptor modulators
#59Vitamin D receptor modulators
#60Benzoic Acid Derivatives that are Modulators or Agonists of GlyR
#61Functionalized sinapic acid and methyl sinapate
#62BIARYLOXYMETHYLARENECARBOXYLIC ACIDS AS GLYCOGEN SYNTHASE ACTIVATORS
#63NOVEL COMPOUNDS AND PHARMACEUTICAL USE THEREOF
#64PROCESS AND INTERMEDIATES FOR PREPARING INTEGRASE INHIBITORS
#65Photosensitive compound and photoresist composition including the same
#66Vitamin D receptor modulators
#67Use of aryl chlorides in palladium-catalyzed C-H bond functionalization
#68Receptor function regulator
#69Transthyretin Stabilization
#70High-Purity Oxydiphthalic Acid Anhydride and Process for Producing the Same
#71Carboxilic acid derivatives
#72Biaryloxymethylarenecarboxylic acids as glycogen synthase activator
#73Process and intermediates for preparing integrase inhibitors
#74Biaryloxymethylarenecarboxylic acids as glycogen synthase activator
#75Method for the preparation of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid
#76Dicarboxylic acid derivatives with pharmaceutical properties
#77Method for the treatment of metabolic disorders
#78Benzene compound having 2 or more substituents
#79Naphthalene compounds as selective estrogen receptor modulators
#80Process for the preparation of substituted 2-(phenoxymethyl)benzoic acids
#81Method for producing carboxylic acid compound
#82Perdeuterated polyimides, their process of preparation and their use as materials which are transparent within the region from 2500 to 3500 cm
#83Perdeuterated polyimides, their process of preparation and their use as materials which are transparent within the region from 2500 to 3500 cm-1
#84Compounds useful for the treatment of diseases associated with the formation of amyloid fibrils
#85Unsymmetrical aromatic ether diacids and absorbable polymers therefrom
#86Method for making polyetherimides
#874-SUBSTITUTED 2-ARYLOXYPHENOL DERIVATIVES AS ANTIBACTERIAL AGENTS
#88Compounds
#89Compounds for the treatment of metabolic disorders
#90Phenyl compounds
#91Direct dianhydride synthesis
#92Ligands of adenine nucleotide translocase (ant) and compositions and methods related thereto
#93KCNQ channel modulating compounds and their pharmaceutical use
#94Therapeutic molecules and methods-1
#95Method of purifying dianhydrides
#96Biaryloxymethylarenecarboxylic acids as glycogen synthase activators
#97Napththalene derivatives which inhibit the cytokine or biological activity of microphage migration inhibitory factor (mif)
#98Hexafluoroisopropanol substituted ether derivatives
#99N-Benzodioxolyl, n-benzodioxanyl and n-benzodioxepinyl arylcarboxamide derivatives and pharmaceutical compositions comprising them
#100Ligands of adenine nucleotide translocase (ANT) and compositions and methods related thereto
#101Compounds, compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding
#102Compounds, compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding
#103Transthyretin stabilization
#104Perdeuterated polyiimides, their process of preparation and their use as materials which are transparent within the region from 2500 to 3500cm
#105Dicarboxylic acids for dielectrics having barrier effect against copper diffusion
#106Process for the preparation of substituted 2-(phenoxymethyl) benzoic acids
#107Halogen-containing aromatic compound
#108Preparation of polyaryl carboxylic acids
#109Diaryl ether condensation reactions
#110Thyroid receptor ligands